(Q53632241)
Statements
PS01.56: IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1-Selected Chemotherapy-Naive NSCLC Patients: Topic: Medical Oncology. (English)
Jacek Jassem
1 reference
Roy S Herbst
Simonetta Mocci
Filippo De Marinis
Sivuonthanh Lam
Alan Sandler
Ariel Lopez-Chavez
Yu Deng
Giuseppe Giaccone
David R Spigel
28 October 2016
11
11S
S304-S305